BioCentury | Apr 28, 2016
Distillery Therapeutics

Therapeutics: microRNA-3188 (MIR3188); forkhead box O1 (FOXO1)

...MIR3188 or FOXO1 could help treat nasopharyngeal carcinoma (NPC). In patients, low tumor levels of MIR3188...
...expression of MIR3188 and FOXO1. In two xenograft mouse models of NPC, tumor overexpression of MIR3188...
...alone. Next steps could include identifying compounds that promote expression of MIR3188 or FOXO1. TARGET/MARKER/PATHWAY: microRNA-3188 (MIR3188)...
Items per page:
1 - 1 of 1